Odyssean »

Alerus Finl shares owned by Odyssean

Quarter-by-quarter ownership of Alerus Finl (ALRS) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Alerus Finl

Tip: Access up to 7 years of quarterly data

All positions including Alerus Finl held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alerus Finl by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $584k 19k 31.10

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Alerus Finl

Alerus Financial
BlackRock
Vanguard Capital Management
Dimensional Fund Advisors
Geode Capital Management
Goldman Sachs Group
State Street Corporation
M3F
Ameriprise Financial
Stieven Capital Advisors
Phocas Financial
Banc Funds Company
Endeavour Capital Advisors
Rsm Us Wealth Management
American Century Companies

View all funds holding Alerus Finl